logo-large
  • Browse Categories

Publications by authors named "Simone V Bigi"

Claim this Profile
D
Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships.
Masato Yoshikawa, Morihisa Saitoh, Taisuke Katoh, Tomohiro Seki, Simone V Bigi

J Med Chem· March 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure".
Marion Lanier, Jason Pickens, Simone V Bigi, Erica L Bradshaw-Pierce, Alison Chambers

ACS Med Chem Lett· December 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure.
Marion Lanier, Jason Pickens, Simone V Bigi, Erica L Bradshaw-Pierce, Alison Chambers

ACS Med Chem Lett· March 2017


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-based drug discovery of potent and selective MKK3/6 inhibitors.
Mark Adams, Toshitake Kobayashi, J David Lawson, Morihisa Saitoh, Kenichiro Shimokawa, Simone V Bigi

Bioorg Med Chem Lett· February 2016


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: